RYAHF (RYAH Group) Common Stock: $36.49 Mil (As of Sep. 2022)


What is RYAH Group Common Stock?

RYAH Group RYAHF Common Stock is $36.49 Mil as of Sep. 2022.

RYAH Group's quarterly common stock increased from Mar. 2022 ($36.16 Mil) to Jun. 2022 ($36.49 Mil) but then stayed the same from Jun. 2022 ($36.49 Mil) to Sep. 2022 ($36.49 Mil).

RYAH Group's annual common stock increased from . 20 ($0.00 Mil) to Dec. 2020 ($24.98 Mil) and increased from Dec. 2020 ($24.98 Mil) to Dec. 2021 ($36.13 Mil).


RYAH Group Common Stock Historical Data

* Premium members only.

The historical data trend for RYAH Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Common Stock Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Common Stock
24.98 36.13

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial 37.42 36.13 36.16 36.49 36.49

RYAH Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $36.49 Mil mean?
RYAH Group (RYAHF) has a Common Stock of $36.49 Mil as of Sep. 2022. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RYAH Group and its competitors.
Is RYAH Group's Common Stock too high?
RYAH Group's current Common Stock is $36.49 Mil.
How does RYAH Group's Common Stock compare to CERN and VEEV?
RYAH Group's Common Stock of $36.49 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RYAH Group and its competitors. RYAH Group's current Common Stock is $36.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Common Stock of $36.49 Mil. The current Common Stock is $36.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Common Stock is $36.49 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.